EPA establishes pesticide residue tolerances for pydiflumetofen on sugarcane and cane commodities following Syngenta Crop Protection's petition under the Federal Food, Drug, and Cosmetic Act.
National Institute of Diabetes and Digestive and Kidney Diseases announces an amended meeting notice for its advisory council to discuss research priorities and funding initiatives affecting small biotech and life-sciences firms.
Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.
Center for Scientific Review amends meeting notice regarding review panels and grant evaluation procedures for National Institutes of Health funding decisions.
National Institute on Aging offers licensing opportunities for 4-amino-2-(piperidin-3-yl)isoindoline-1,3-diones, pre-clinical anti-inflammatory compounds targeting systemic and neurodegenerative disorders, to qualified research and commercialization…
National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.
EPA announces receipt of new chemical submissions under TSCA during March 2026, including premanufacture notices, significant new use notices, and biotechnology exemption applications, with opportunity for public comment.
EPA proposes to modify its January 2025 ozone reclassification rule nationwide, allowing states to apply only current-classification requirements rather than prior-classification State Implementation Plan obligations upon area reclassification.
Center for Scientific Review will hold closed National Institutes of Health review meetings to evaluate grant applications across multiple scientific disciplines during specified dates in 2024 and 2025.
National Institute of Biomedical Imaging and Bioengineering announces a public meeting to discuss research funding priorities and grant opportunities for biomedical imaging and bioengineering projects.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
